G.O Strategic Advisors, LLC
New York | USA
  • LinkedIn -GO Strategic Advisors
  • Twitter - GO Strategic Advisors
Guarda Oltre
Look Beyond

©G.O Strategic Advisors 2017. Website by Let's Start Design

Guarda Oltre 

An Italian phrase with a deeper meaning than the literal translation.  Guarda Oltre implies looking deeper and beyond what is understood or seen, to consider that we do not know yet what that deeper meaning could be.  It means to consider something else in the direction you are looking that could be more important for you to pay attention to.  This is our philosophy at G.O Strategic Advisors. 

It is our mission at G.O Strategic Advisors to combine our passion for change in healthcare with perspective and deep insights developed from broad industry experience to assist you to achieve more.  We are driven by our personal and professional experiences in chronic care delivery.  We see a better way that includes the broader population and the health and wellness of people in a holistic sense.  We are here to help improve the overall health-based experience across the entire community and remove the fog that obscures the path forward.  Come join us.

Our experience includes working with health plans on strategies associated with product design and pricing, network design and claims cost management. We have also assisted providers in considering population health management opportunities. These include understanding the metrics and process challenges associated with quality improvement, and the infrastructure and data/analytic enablement required to launch population health based strategies.

 

We have assisted provider organizations evaluate alternative business strategies such as clinical integrated networks and options aligned with outcomes based incentives / transition from fee for service to value based contracting.  

We all  know healthcare is complex and intricate.  It is as much about community, food, and jobs as it is about patient experience and clinical effectiveness.  It is also a part of our lives that until recently has not seen significant change.  We have experienced a slow maturity in clinical delivery and drug therapies over the past several thousands of years.  This pace greatly accelerated in the past 100 years.  The change we are experiencing now however is exponential in comparison. 

 

The initiatives today range from a better understanding of how social determinants impact our preferences as individuals, as well as a patient.  Bio-medical advancements and genetic research are coming together to create personalized therapies.  Bionics and exoskeleton technology rethink the medical devices space. 

Global communities have the opportunity to combine data and identify clinically proven, evidence based standards and guidelines.  We are collecting real-time data from devices in our pockets.  We are building new processes and interfaces that impact all aspects of the value chain.  We are expanding the concept of "health" and  "care" through revolutionary advancements that are intertwined with emerging and potentially disruptive business models. 

This is not the time to settle for observations and conclusions that focus on the problem in front of us, but rather is a time we must dig deep and look beyond to see the inter-connections and broader issues.  

Guarda Oltre.

 

Mark Jamilkowski has been assisting health enterprises for almost 30 years as a strategic consultant and an actuary.  Mark has extensive experience solving complex issues with a focus on practical solutions and bottom-line results.  He helps clients bridge strategic initiative into successful execution, especially with such initiatives as value based contracting, population health based initiatives insurance product design, and consumer (patient) engagement.  Mark is passionate about how the industry is collecting healthcare data from emerging technology and analyzing it to support these initiatives.

His experience includes working with health plans on strategies associated with product design and pricing, network design and claims cost management.

Mark has also assisted providers in considering population health management opportunities, including understanding the metrics and process challenges associated with quality improvement, and the infrastructure and data/analytics required to launch population health based strategies.  He has also helped provider organizations evaluate alternative business strategies such as clinical integrated networks and options aligned with outcomes based incentives / transition from fee for service to value based contracting.  

 

Mark is a motivating leader and mentor who excels at guiding others to achieve professional and personal growth.